| Literature DB >> 1709572 |
T Furukawa1, M Takahashi, Y Moriyama, T Koike, I Kurokawa, A Shibata.
Abstract
A patient with chronic idiopathic neutropenia, who had been suffering from repeated infections, was successfully treated with recombinant granulocyte stimulating factor (rhG-CSF). Subcutaneous injection of 30 micrograms/m2 rhG-CSF every two days was sufficient to maintain the neutrophil count at approximately 1,000/microliter. The patient has lived without any evidence of infection for the last 10 months using that treatment. There were no side effect caused by rhG-CSF and antibodies against G-CSF were not detected in the patient's plasma.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1709572 DOI： 10.1007/bf01714979
Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673